Intensive Care Unit

Caring for patients in the ICU is extremely complex; managing your equipment shouldn’t be.

Improved Efficiencies and Lower Cost

Bring economic value to your organization through the use of one simple, yet versatile system used to deliver kidney replacement therapy throughout the continuum of patient care while in the ICU.

The NxStage® System One™ can be used whether your patients require continuous 24-hour therapy or are stable enough to endure intermittent treatments.

The use of one system across the continuum of patient care allows the ICU nurse to manage the patient, while freeing the dialysis nurse to care for other patients or manage other responsibilities.

Unique volumetric fluid balancing system contributes to cost savings.

nxnh
  • Eliminate the need for treated water sources and related testing/maintenance1
  • Eliminate waste bags, reducing cost of bags and interruptions in patient therapy

Patient and Staff Safety

  • The NxStage System One and disposable components incorporate innovative safety features to help minimize risk to patients and employees.
  • PureFlow™ B pre-mixed therapy solutions, available in a wide range of electrolyte formulations, can help correct and manage acidosis and reduce potential risks of compounding errors.2
  • Fully-integrated Cartridges available with SecureClip® reduce the risk of blood loss from accidental tubing disconnects.

The Department of Labor's Bureau of Labor Statistics (BLS) cites more than 35,000 back and other injuries among nurses every year; severe enough to miss work.3

  • A unique volumetric fluid balancing system built into the disposable cartridge allows direct-to-drain waste lines, eliminating the need to lift, carry, and empty waste bags, reducing the risk of back injury or effluent splash back
  • Use of one small portable system eliminates the need for employees to transport heavy conventional IHD equipment to and from the ICU.
  • Needleless luer valves comply with needle-free policies and legislation and protect air from getting into the circuit.5

Software Security

NxView™ permanently stores, retrieves and protects treatment data from unintended changes by users or viruses.1

nxnh

Increased Nursing Competencies

Improve RN competencies and prevent errors from occurring with more frequent use of one simple system for renal replacement therapies in the ICU.4 In addition, intuitive on-screen instructions help ensure proper steps are followed to prevent errors.

Improve infection control and reduce infectious disease exposure risks

According to the CDC, on any given day, about 1 in 25 hospital patients has at least one healthcare-associated infection.2

Needlesticks occur every day

  • On average, more than 1,500 needlesticks and other sharps injuries occur daily in the United States3
  • It only takes one needlestick to transmit up to 30 blood-borne pathogens, including HBV, HCV, and HIV5

The consequences of 1 needlestick

  • The potential changes to health and the stress of the testing process can be devastating for the affected caregiver.
  • A dialysis provider may incur healthcare costs up to $4,8385

Eliminate the risk of needlestick injuries with needleless luer valves.

Reduce the risk of staff exposure to patient blood with the SecureClip®, which augments patient access connections.

The overall range of costs for reported exposures was between $71 - $4,838 depending on the severity and infection status of the source patient.

Contact Us For More Information

Learn more about how NxStage products and therapies can help you and your patients.

References:

  1. NxStage System One User Guide. NC4921 Rev M 2022-07.
  2. Concepcion LA, et al. ARF requiring dialysis; use of shift CVVHD vs conventional dialysis. J Am Soc Nephrol, 2009; Suppl, F-P01557 (Abstract).
  3. Gashti CN, Salcedo S, Robinson V, Rodby RA. Accelerated venovenous hemofiltration: early technical and clinical experience. Am J Kidney Dis. 2008; 51(5):804-810.
  4. D. M. Nash, S Przech, R. Wald, and D. O’Reilly, “Systematic review and meta-analysis of renal replacement therapy modalities for acute kidney injury in the intensive care init,” Journal of Critical Care, vol. 41, pp. 138-144, 2017.
  5. Kraus MA. Selection of Dialysate and Replacement Fluids and Management of Electroyte and Acid-Base Disturbances. Seminars in Dialysis; Vol 22, No 2 (March-April) 2009 pp. 137-140.
  6. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012; 2:1-138.

 

Risks and Responsibilities

Renal replacement therapy, as with any medical therapy is not without risks. The decision of which therapy and medical device to use should be made by the physician, based on previous experience and on the individual facts and circumstances of the patient.

There is no literature demonstrating that one therapy is clinically better than the other.6

The use of anticoagulation is at the discretion of the prescribing physician.

 

© 2024 Fresenius Medical Care. All Rights Reserved. Fresenius Medical Care, the triangle logo, NxStage, System One and NxView are trademarks of Fresenius Medical Care Holdings, Inc. or its affiliated companies. All other trademarks are the property of their respective owners.

CAUTION: Federal law restricts this device to sale by or on the order of a physician

APM2193 Rev. D